Postdoctoral Scientist - Gonococcal Vaccine Group

An exciting opportunity has arisen for a Postdoctoral Scientist to work in the Gonococcal Vaccine Project at the Jenner Institute, a world-leading Academic Institute for vaccine development, with over 50 vaccines taken through clinical trials in the UK and Africa to date. You will be responsible for organising and conducting studies “in vivo” samples to understand the immunological basis of protection against gonorrhoea. You will develop processes, assays and methodologies to probe immune responses to gonococcal infection and vaccination with candidate Gonococcal Vaccines. This will include develop and optimize assays to measure immune response to gonococcus, interaction with the vaccine development team and liaise with external partners, particularly with regards to human immunological studies. You will also train other members of the group on relevant specialist methodologies and supervise students as required. Within your responsibilities, you will write research articles for peer-reviewed journals to describe findings, as well as present data at internal/external seminars and conferences. It is essential that you hold a PhD, or close to completion, in immunobiology or a subject relevant to immunobiology, together with experience of microbiology and development of methodologies in immunology and microbiology. You should have a publication record appropriate for this stage of your career. It is essential that you are able to analyse, interpret and present scientific data and write factual reports. You should be willing to conduct studies “in vivo” samples to understand the immunological basis of protection against gonorrhoea. Applications for this vacancy are to be made online and you will be required to upload a supporting statement and CV as part of your online application. Your supporting statement must explain how you meet each of the selection criteria for the post using examples of your skills and experience.  This position is offered full time on a fixed term contract until 10 April 2025 and is funded by the CARB-X.  Only applications received before 12 midday on Thursday 8 February 2024 will be considered. Please quote 170521 on all correspondence.